The supplementation of mulberry leaf extract, along with fibre, vitamin D, and chromium, has been shown to reduce post meal glucose spike, according to a study funded by Nestle Health Science on one of its products.
Nestlé Health Science and Enterome are to co-develop and commercialise a series of microbiome-based immunotherapies for food allergies and inflammatory bowel disease (IBD).
This round-up will look at developments of brands in the health and nutrition industry, including how brands such as Bubs Australia and Bellamy’s Organic have successfully gained access to the infant formula market in US, as well as Nestle Health Science’s...
Nestlé Health Science has agreed to acquire weight management service, PronoKal (PnK) from investment company, Abac Capital, to “add a new dimension” to its weight management portfolio.
Nestlé Health Science has launched a new online platform that focuses on the importance of nutrition for patients and carers of those undergoing cancer treatment.
Nestle Health Science has launched a mulberry leaf supplement, Nutren GlucoSmart, that disrupts the digestion of carbohydrates to protect pre-diabetics from developing full blown type 2 diabetes.
New product development for glucose control and diabetes prevention nutrition are cutting across new dosage formats, the use of plant-based ingredients, pre/probiotics, and even the inclusion of artificial intelligence (AI) to make health decisions, according...
Nestlé Health Science has announced the acquisition of two brands belonging to specialised nutrition firm Dr Schär that addresses Inborn Errors of Metabolism (IEM) and cow’s milk protein allergy.
Nestlé Health Science announces the start of a partnership to commercialise a self‐expanding capsule that trials have shown triggers the feeling of satiety via the gut–brain axis thereby leading to weight loss.
Nestlé Health Science has agreed to acquire a majority stake in Chicago-based Vital Proteins, adding the leading collagen brand to its other vitamin, mineral, supplement and wellness brands, including Atrium Innovations, Garden of Life, Pure Encapsulations...
Nestlé Health Science is to sell its products direct to consumers in 20 markets, after signing a partnership with the THG (The Hut Group) e-commerce platform.
Amsterdam-based microbiome specialist Caelus Health has entered into a strategic collaboration with Nestlé Health Science as it looks to develop and ultimately commercialise microbiome-based food supplements.
California-based ChromaDex announced that Nestlé Health Science now has “exclusive right” to include ChromaDex’s patented nicotinamide riboside ingredient Tru Niagen in its branded medical nutrition products.
Bristol-Myers Squibb and Principia SGR join existing investors including Nestlé Health Science and Seventure
French biotech Enterome will step up its development of microbiome-based clinical therapeutics for IBD and cancer after raising €32 million in Series D Financing.
Microbiome firm Enterome will move its research laboratories to a French biocluster specialising in biotechnology, genomics and genetics, the firm said.
A joint venture between microbiome-focused Enterome and Nestlé Health Science will focus on the discovery and commercialisation of innovative diagnostics for a variety of microbiome-related diseases.
Nestlé has bought its second brain health-focused medical foods start-up in eight months after snaffling Red River Pharma-owned Pamlab which makes high-dose vitamin supplements targeting depression, diabetes and Alzheimer’s.
Nestlé has amplified its nutrition presence by forming a joint venture to develop Traditional Chinese Medicines (TCM). Orally consumed gastro products will be first off the rank based on an extract from the andrographis paniculata plant grown in Indian...
Nestlé is combining its Nestlé Nutrition and Nestlé Health Science arms under the leadership of Luis Cantarell after the departure of Kurt Schmidt, the deputy executive vice president in charge of Nestlé Nutrition for “personal reasons” and to pursue...
The world’s biggest food player, Nestlé, is investing A$17m (€13.6m) to renovate an Australian facility so it can produce medical foods for its Health Science division.
The new Health Science division Nestlé created last September has made its second acquisition by buying $250m a year US gastroenterology and oncology diagnostic specialist, Prometheus Laboratories Inc., for an undisclosed sum.
Nestlé Health Science, the division the food giant created in September last year to research and develop medical and functional foods, has bought UK medical foods start-up CM&D Pharma Limited, with more acquisitions – both small and large – set to...
Nestlé has announced the creation of two new organisations to develop personalised health science nutrition to prevent and treat health conditions such as diabetes, obesity, heart disease and Alzheimer's.